Consolidated Net Income/Loss (Annual)

Consolidated Net Income/Loss: A company's total income or loss before preferred stock dividends.

CVS Health Corporation (CVS) had Consolidated Net Income/Loss of $1.73B for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$402.07B
Net Income	$1.77B
Cost of Goods Sold	$221.17B
Gross Profit	$180.90B
Operating Expenses	$397.41B
Operating Income	$4.66B
Non-Operating Income/Expense	$-2.52B
Pre-Tax Income	$2.14B
Normalized Pre-Tax Income	$2.14B
Income after Taxes	$1.73B
Income from Continuous Operations	$1.73B
Consolidated Net Income/Loss	$1.73B
Normalized Income after Taxes	$1.73B
EBIT	$4.66B
EBITDA	$14.99B
Weighted-Average Shares Outstanding (Basic)	1.27B
Weighted-Average Shares Outstanding (Diluted)	1.27B
Earnings per Share (EPS) (Basic)	$1.40
Earnings per Share (EPS) (Diluted)	$1.39
Balance Sheet Financials
Current Assets	$74.71B
Property, Plant, and Equipment	$13.08B
Long-Term Assets	$178.82B
Total Assets	$253.54B
Current Liabilities	$88.69B
Long-Term Debt	$60.50B
Long-Term Liabilities	$89.46B
Total Liabilities	$178.16B
Common Equity	$75.38B
Tangible Shareholders Equity	$-35.60B
Shareholders Equity	$75.38B
Common Shares Outstanding	1.27B
Cash Flow Statement Financials
Cash Flow from Operating Activities	$10.64B
Cash Flow from Investing Activities	$-5.87B
Cash Flow from Financial Activities	$-4.94B
Beginning Cash	$8.88B
End Cash	$8.71B
Increase/Decrease in Cash	$-172.00M
Stock-Based Compensation	$535.00M
Common Stock Dividends Paid	$-3.40B
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	0.84
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.45
Debt to Equity Ratio	0.86
Gross Margin	44.99%
Operating Margin	1.16%
EBIT Margin	1.16%
EBITDA Margin	3.73%
Pre-Tax Profit Margin	0.53%
Profit Margin	0.44%
Free Cash Flow	$7.81B
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.59
Inventory Turnover	11.49
Receiveable Turnover	10.11
Days Sales in Receivables	36.11
Return on Equity	2.29%
Return on Tangible Equity	-4.85%
Return on Assets	0.68%
Return on Investments	1.27%
Book Value Per Share	$59.31
Free Cash Flow per Share	$6.14
Operating Cash Flow per Share	$8.37

Data from Zacks Investment Research, Inc.